SCLERO.ORG
Search
Scleroderma Newsroom
ISN News Manager: Jo Frowde
Autoimmune
Media Stories
Scleroderma
ISN/Website
Media News Archive
We maintain news archives for the most recent 3 years.
2020: Jan Feb Mar Apr May Jun Jul
2020 - 2019 - 2018 - 2017

July 2020 Media News

'No-swab' saliva test for coronavirus piloted in Britain. A weekly coronavirus testing regime using a “no-swab” saliva test is being trialled in Southern England, and could result in a simpler and quicker way to detect outbreaks of the virus, the British government said. Reuters Health, 06/22/2020.

Novartis halts malaria drug trial against COVID-19 amid participant shortfall. Novartis is halting its trial of malaria drug hydroxychloroquine against COVID-19 after struggling to find participants, as data emerged from other studies raising doubts about its efficacy. Reuters Health, 06/19/2020. (Also see DMARDs)

How dentists aim to keep patients healthy and prevent coronavirus spread. Many dental offices are taking safety precautions to keep urgent appointments safe for both patients and dentists. NBC Health News, 06/21/2020. (Also see Dental Fears, Difficulties and Phobias)

How scientists test face mask effectiveness against coronavirus. Scientists around the world have conducted research that finds wearing face masks can significantly decrease the spread of the coronavirus when a person coughs, sneezes, or talks. NBC Health News, 06/21/2020.

How Those With Obsessive-Compulsive Disorder Cope With Added Angst Of COVID. This pandemic has been really difficult for people battling obsessive-compulsive disorder and other mental health issues. Kaiser Health News, 06/22/2020. (Also see Anxiety and Attitude)

You May Have Antibodies After Coronavirus Infection, But Not for Long. Antibodies to the virus faded quickly in asymptomatic people, scientists reported. That does not mean immunity disappears. New York Times, 06/20/2020. (Also see Antibodies)

Six Months of Coronavirus: Here’s Some of What We’ve Learned. Much remains unknown and mysterious, but these are some of the things we’re pretty sure of after half a year of this pandemic. New York Times, 06/20/2020.

A Low-Cost Steroid Shows Promise for Treating COVID-19. But Take the News With a Grain of Salt. Researchers looking into potential COVID-19 treatments are being hailed as a “groundbreaking development”— but recent history shows it’s worth taking these promising findings with a grain of salt. Time Healthland, 06/16/2020.

Americans Are the Unhappiest They Have Been in 50 Years: Poll.It’s been a rough year for the American psyche. Folks in the U.S. are more unhappy today than they’ve been in nearly 50 years. Time Healthland, 06/16/2020. (Also see Depression)

Is THIS why diabetes sufferers are vulnerable to coronavirus? Scientists have discovered a pattern that may help explain why people with chronic diseases are at greater risk from coronavirus. Mail Online, 06/16/2020.

Go to Scleroderma Media News: June 2020
 

We have the world's best supporters! See ISN News.

 

SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses. We are a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected]. Disclaimer. Privacy Policy.
 

The most important thing in the world to know about scleroderma is sclero.org!